Fellowship · Houston, TX
Sponsored by University of Texas Health Science Center at Houston
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Autophagy · 2021 · 2,291 citations · John Livingston
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 213 citations · Branko Cuglievan
Osteosarcoma.
Nature reviews. Disease primers · 2022 · 559 citations · Jonathan Gill, John Livingston, Richard Gorlick
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
Nature · 2023 · 458 citations · Branko Cuglievan
Advancing therapy for osteosarcoma.
Nature reviews. Clinical oncology · 2021 · 673 citations · Jonathan Gill, Richard Gorlick
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
The New England journal of medicine · 2023 · 303 citations · Miguel Escobar
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.
CA: a cancer journal for clinicians · 2022 · 245 citations · Michael Roth
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 146 citations · John Livingston